CausalSentinel

Protein Dossier — AKR1A1 (Aldo-keto reductase family 1 member A1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.033 0.0108 0.00237 Wald ratio 1 cis NA
Non-cancer illness code self-reported: gastro-oesophageal reflux (gord) or gastric reflux 0.0549 0.0198 0.00557 Wald ratio 1 cis NA
ER-positive Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.035 0.0128 0.00624 Wald ratio 1 cis NA
High grade serous ovarian cancer 0.0708 0.0286 0.0132 Wald ratio 1 cis NA
Diagnoses - main ICD10: K57 Diverticular disease of intestine 0.0691 0.0285 0.0154 Wald ratio 1 cis NA
Diagnoses - main ICD10: I84 Haemorrhoids -0.0696 0.0299 0.02 Wald ratio 1 cis NA
Nucleus accumbens volume -4.5 2 0.0246 Wald ratio 1 cis NA
Ovarian cancer 0.0519 0.024 0.0303 Wald ratio 1 cis NA
Diagnoses - main ICD10: J33 Nasal polyp -0.161 0.0746 0.0306 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hiatus hernia -0.0584 0.0302 0.0533 Wald ratio 1 cis NA
Fracture resulting from simple fall -0.0224 0.0119 0.0592 Wald ratio 1 cis NA
Non-cancer illness code self-reported: arthritis (nos) -0.103 0.0556 0.0647 Wald ratio 1 cis NA
…and 68 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4192_10_2 AK1A1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

48 association rows across 35 traits (46 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Ribitol levels 2e-123 rs2229540 1 GCST90139610 no MR -> candidate analysis
Alcohol dehydrogenase [NADP(+)] levels 5e-68 rs2229540 2 GCST90162010 no MR -> candidate analysis
Erythritol levels 4e-64 rs2229540 3 GCST90245187 no MR -> candidate analysis
Height 4e-50 rs518365 3 GCST90245848 no MR -> candidate analysis
Peroxiredoxin-1 levels 2e-48 rs2356552 1 GCST90248961 no MR -> candidate analysis
platelet count (mean, inv-norm transformed) 5e-39 rs11211137 1 GCST90480651 no MR -> candidate analysis
platelet count (maximum, inv-norm transformed) 3e-34 rs11211137 1 GCST90480650 no MR -> candidate analysis
Urine ribitol levels in chronic kidney disease 1e-31 rs2229540 1 GCST90265910 no MR -> candidate analysis
Creatinine levels 2e-27 rs35349030 3 GCST90662902 no MR -> candidate analysis
Circulating PRDX1 levels 6e-25 rs2356552 1 GCST90860183 no MR -> candidate analysis
Estimated glomerular filtration rate (creatinine) 1e-24 rs499600 1 GCST90100220 no MR -> candidate analysis
PRDX1 protein levels 1e-23 rs2356552 2 GCST90470315 no MR -> candidate analysis
…and 23 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 551 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
heart failure 0.211 common-variant locus no MR -> candidate analysis
deep vein thrombosis 0.119 common-variant locus no MR -> candidate analysis
Arthralgia 0.081 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Aldo-keto reductase family 1 member A1)
gnomAD constraint pLI=2.2e-06, LOEUF=0.921 — LoF-tolerant
GWAS Catalog 87 unique SNPs / 173 rows
ClinVar 69 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance